For instance, UNC0638 is a substrate-competitive, quinazoline-derivative G9A inhibitor that has been shown to reduce cancer cell viability, suppress migration and invasion and trigger apoptosis in neuroblastoma, breast and kidney cancer cells (Bellamy et al., 2020; Li R. et al., 2021; Liu et al., 2018). This evidence concerns the gene EHMT2 and cancer.